TRAF-interacting Protein (TRIP): A Novel Component of the Tumor Necrosis Factor Receptor (TNFR)- and CD30-TRAF Signaling Complexes That Inhibits TRAF2-mediated NF-κB Activation
J Exp Med (1997) 185 (7): 1275–1286.
Currently there are no citedby results. Try again later.
